Selective Cyclooxygenase 2 Inhibitors (NSAIDs)

All categories
DBCAT000887Pharmacologic class

A subclass of cyclooxygenase inhibitors with specificity for CYCLOOXYGENASE-2. A DrugBank category of 20 drugs. 14 of them are approved.

Part of
Anti-Inflammatory Agents, Non-Steroidal
Also known as
Inhibitors, Selective COX-2 · Inhibitors, Selective COX2 · Inhibitors, Selective Cyclooxygenase 2 · Inhibitors, Selective Cyclooxygenase-2 · Selective COX 2 Inhibitors
Drugs

What you can answer from here — as of October 27, 2022

20DrugsEach linked to its full drug card
Listed above
20Drug targetsEvery drug–target pair in the class, with bond type
Sign in
5,389Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
11Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Selective Cyclooxygenase 2 Inhibitors (NSAIDs) share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In